AMBIRIX injection suspension medication leaflet

J07BC20 hepatitis A vaccine (inactivated) + hepatitis B vaccine • Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines

The hepatitis A (inactivated) vaccine and hepatitis B vaccine are used to prevent infections caused by the hepatitis A and B viruses, which can lead to liver inflammation and severe complications such as liver failure or cirrhosis.
Hepatitis A (inactivated) vaccine:

This vaccine contains inactivated (killed) hepatitis A virus and is used to prevent hepatitis A, a disease transmitted through contaminated food or water or direct contact with an infected person. The vaccine is administered intramuscularly, usually in two doses, 6-12 months apart. It is recommended for travelers to endemic areas, children, healthcare workers, and other high-risk groups.

Side effects are usually mild and include pain at the injection site, fatigue, or mild fever.
Hepatitis B vaccine:

This vaccine contains the hepatitis B surface antigen (HBsAg) and is used to prevent hepatitis B, a disease transmitted through blood, bodily fluids, or from mother to child during childbirth. The vaccine is administered intramuscularly, usually in three doses over a 6-month period. It is recommended for all newborns, healthcare workers, and individuals at high risk of exposure.

Side effects are rare and include pain at the injection site, fatigue, or mild fever.

General data about AMBIRIX

Substance: hepatitis A vaccine (inactivated) + hepatitis B vaccine

Date of last drug list: 01-07-2013

Commercial code: W51445001

Pharmaceutical form: injection suspension

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Other substances similar to hepatitis A vaccine (inactivated) + hepatitis B vaccine